DIPS (Dystonia Image-based Programming of Stimulation: a prospective, randomized, double-blind crossover trial)

被引:3
|
作者
Lange, Florian [1 ,2 ]
Roothans, Jonas [1 ,2 ]
Wichmann, Tim [1 ,2 ]
Gelbrich, Goetz [3 ,4 ]
Roeser, Christoph [4 ]
Volkmann, Jens [1 ,2 ]
Reich, Martin [1 ,2 ]
机构
[1] Univ Hosp, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany
[2] Julius Maximilian Univ, Josef Schneider Str 11, D-97080 Wurzburg, Germany
[3] Univ Wurzburg, Inst Clin Epidemiol & Biometry ICE B, Josef Schneider Str 2, D-97080 Wurzburg, Germany
[4] Univ Wurzburg, Clin Trial Ctr CTC, Josef Schneider Str 2, D-97080 Wurzburg, Germany
来源
NEUROLOGICAL RESEARCH AND PRACTICE | 2021年 / 3卷 / 01期
关键词
Deep brain stimulation; Dystonia; Imaging-guided DBS programming; DEEP-BRAIN-STIMULATION; CERVICAL DYSTONIA; IMPACT;
D O I
10.1186/s42466-021-00165-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
IntroductionDeep brain stimulation of the internal globus pallidus is an effective treatment for dystonia. However, there is a large variability in clinical outcome with up to 25% non-responders even in highly selected primary dystonia patients. In a large cohort of patients we recently demonstrated that the variable clinical outcomes of pallidal DBS for dystonia may result to a large degree by the exact location and stimulation volume within the pallidal region. Here we test a novel approach of programing based on these insights: we first defined probabilistic maps of anti-dystonic effects by aggregating individual electrode locations and volumes of tissue activated of > 80 patients collected in a multicentre effort. We subsequently modified the algorithms to be able to test all possible stimulation settings of de novo patients in silico based on the expected clinical outcome and thus potentially predict the best possible stimulation parameters for the individual patients.MethodsWithin the framework of a BMBF-funded study, this concept of a computer-based prediction of optimal stimulation parameters for patients with dystonia will be tested in a randomized, controlled crossover study. The main parameter for clinical efficacy and primary endpoint is based on the blinded physician rating of dystonia severity reflected by Clinical Dystonia Rating Scales for both interventions (best clinical settings and model predicted settings) after 4 weeks of continuous stimulation. The primary endpoint is defined as "successful treatment with model predicted settings" (yes or no). The value is "yes" if the motor symptoms with model predicted settings are equal or better (tolerance 5% of absolute difference in percentages) to clinical settings. Secondary endpoints will include measures of quality of life, calculated energy consumption of the neurostimulation system and physician time for programming.PerspectiveWe envision, that computer-guided deep brain stimulation programming in silico might provide optimal stimulation settings for patients with dystonia without the burden of months of programming sessions. The study protocol is designed to evaluate which programming method is more effective in controlling motor symptom severity and improving quality of life in dystonia (best clinical settings and model predicted settings).Trial registration Registered with ClinicalTrials.gov on Oct 27, 2021 (NCT05097001).
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Effect of Topical Steroid on Swallowing Following ACDF Results of a Prospective Double-Blind Randomized Control Trial
    Kim, Han Jo
    Alluri, Ram
    Stein, Dan
    Lebl, Darren
    Huang, Russel
    Lafage, Renaud
    Bennett, Tianna
    Lafage, Virginie
    Albert, Todd
    SPINE, 2021, 46 (07) : 413 - 420
  • [32] Acute supplementation with grapes in obese subjects did not affect postprandial metabolism: a randomized, double-blind, crossover clinical trial
    Garcia-Diez, Esther
    Cuesta-Hervas, Marta
    Veses-Alcobendas, Ana M.
    Alonso-Gordo, Oscar
    Garcia-Maldonado, Elena
    Martinez-Suarez, Miriam
    Herranz, Beatriz
    Vaquero, M. Pilar
    alvarez, Maria Dolores
    Perez-Jimenez, Jara
    EUROPEAN JOURNAL OF NUTRITION, 2021, 60 (05) : 2671 - 2681
  • [33] Randomized double-blind sham-controlled trial of thalamic versus GPi stimulation in patients with severe medically refractory Gilles de la Tourette syndrome
    Mueller-Vahl, K. R.
    Szejko, N.
    Saryyeva, A.
    Schrader, C.
    Krueger, D.
    Horn, A.
    Kuehn, A. A.
    Krauss, J. K.
    BRAIN STIMULATION, 2021, 14 (03) : 662 - 675
  • [34] Short Pulse Width in Subthalamic Stimulation in Parkinson's Disease: a Randomized, Double-Blind Study
    Bouthour, Walid
    Wegrzyk, Jennifer
    Momjian, Shahan
    Peron, Julie
    Fleury, Vanessa
    Chaoui, Emilie Tomkova
    Horvath, Judit
    Boex, Colette
    Luscher, Christian
    Burkhard, Pierre R.
    Krack, Paul
    Zacharia, Andre
    MOVEMENT DISORDERS, 2018, 33 (01) : 169 - 173
  • [35] Melatonin for Neuropathic Pain: Protocol for a Double-blind, Randomized Controlled Trial
    Gilron, Ian
    Tu, Dongsheng
    Holden, Ronald R.
    Moulin, Dwight E.
    Duggan, Scott
    Milev, Roumen
    JMIR RESEARCH PROTOCOLS, 2022, 11 (09):
  • [36] Efficacy of postoperative analgesia with duloxetine in posthemorrhoidectomy pain: a prospective, randomized, double-blind and placebo-controlled trial
    Gerber, Marlus Tavares
    Lyra, Humberto Fenner
    Erdmann, Thomas Rolf
    Bomfati, Fernanda
    Gaspareto, Patrick Barcelos
    de Oliveira Filho, Getulio Rodrigues
    BMC ANESTHESIOLOGY, 2022, 22 (01)
  • [37] Pedunculopontine and Cuneiform Nuclei Deep Brain Stimulation for Severe Gait and Balance Disorders in Parkinson's Disease: Interim Results from a Randomized Double-Blind Clinical Trial
    Bourilhon, Julie
    Olivier, Claire
    You, Hana
    Collomb-Clerc, Antoine
    Grabli, David
    Belaid, Hayat
    Mullie, Yannick
    Francois, Chantal
    Czernecki, Virginie
    Lau, Brian
    Perez-Garcia, Fernando
    Bardinet, Eric
    Fernandez-Vidal, Sara
    Karachi, Carine
    Welter, Marie-Laure
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (02) : 639 - 653
  • [38] Dexamethasone for postadenoidectomy pain reduction. Does it truly work? A prospective randomized double-blind clinical trial
    Frelich, M.
    Divak, J.
    Vodicka, V.
    Bebej, M.
    Sklienka, P.
    Nedopilkova, O.
    JOURNAL OF CLINICAL ANESTHESIA, 2020, 61
  • [39] Dysport and Botox at a Ratio of 2.5:1 Units in Cervical Dystonia: A Double-Blind, Randomized Study
    Yun, Ji Young
    Kim, Jae Woo
    Kim, Hee-Tae
    Chung, Sun Ju
    Kim, Jong-Min
    Cho, Jin Whan
    Lee, Jee-Young
    Lee, Ha Neul
    You, Sooyeoun
    Oh, Eungseok
    Jeong, Heejeong
    Kim, Young Eun
    Kim, Han-Joon
    Lee, Won Yong
    Jeon, Beom S.
    MOVEMENT DISORDERS, 2015, 30 (02) : 206 - 213
  • [40] Directional DBS Increases Side-Effect Thresholds-A Prospective, Double-Blind Trial
    Dembek, Till A.
    Reker, Paul
    Visser-Vandewalle, Veerle
    Wirths, Jochen
    Treuer, Harald
    Klehr, Martin
    Roediger, Jan
    Dafsari, Haidar S.
    Barbe, Michael T.
    Timmermann, Lars
    MOVEMENT DISORDERS, 2017, 32 (10) : 1380 - 1388